Camila Sanz

Researcher in the Department of Physics at the University of Buenos Aires / IFIBA-CONICET

Data updated

Papers

5 publications

Trials

0 clinical trials

Research Footprint

Camila Sanz appears in 5 tracked papers (2018–2022), most studied alongside Psilocybin, LSD and DMT, across Depressive Disorders, Microdosing and Obsessive-Compulsive Disorder (OCD).

Most-cited paper: The Experience Elicited by Hallucinogens Presents the Highest Similarity to Dreaming within a Large Database of Psychoactive Substance Reports (111 citations).

Frequent co-authors: Enzo Tagliazucchi, Claudio Pallavicini and Federico Zamberlan.

Background & Research

Camila Sanz is an Argentine researcher associated with the Department of Physics at the University of Buenos Aires and the Instituto de Física de Buenos Aires (IFIBA-CONICET). Her work appears in psychedelic science on language processing and subjective experience, including studies of psilocybin microdosing, LSD-induced language changes, and semantic analyses of psychoactive-substance reports.

Key Impact

She coauthored multiple influential computational-language studies on psychedelics, including psilocybin microdosing, LSD, hallucinogens, and related altered states of consciousness.

5

Research Papers

View publications →

0

Clinical Trials

Explore trials →

Collaboration Network

12 collaborators· click a node to visit their profile

Full network →

Compounds

PsilocybinLSDDMTKetamineSalvia Divinorum

Topics

Depressive DisordersMicrodosingObsessive-Compulsive Disorder (OCD)CreativityPalliative & End-of-Life DistressAnxiety DisordersBipolar DisorderSchizophreniaSet & SettingEquity and Ethics

Top Collaborators

Affiliations

Institutions, companies, and organisations Camila Sanz is associated with.

University of Buenos Aires

academic

UBA is home to the Consciousness, Culture and Complexity Lab which consists of a multidisciplinary team devoted to the quantitative analysis of high-throughput field and naturalistic studies of human consciousness and cognition. Their sister lab, Phalaris, is specifically dedicated to using psychedelics to study these aspects of neuroscience. Enzo Tagliazucchi oversees the work at both labs. As well as conducting clinical research with psychedelics, Enzo and the team at Phalaris work to make psychedelics visible as native substances of the American continent and advocate for an evidence-based approach toward drug policy.

View stakeholder →